Myriad Ruling: Some Clarity, Some Uncertainty For Biotech
On June 13, 2013, the United States Supreme Court issued its long-awaited decision in Ass'n for Molecular Pathology v. U.S. Patent and Trademark Office, addressing the controversial question of whether DNA...To view the full article, register now.
Already a subscriber? Click here to view full article